In recent times, the novel concept of generating hybrid molecules by pharmacophoric hybridisation approach is fast becoming an alternative to other existing strategies of drug development. These hybrids also known as 'dual drugs' or 'double drugs' are especially found to be effective in overcoming drug resistance problems. Towards this end, a lot of effort has been put for generating 4-aminoquinoline based hybrid molecules as next generation antimalarial drugs effective in malarial chemotherapy. This short review deals about the recent advances carried in the field of 4-aminoquinoline based molecular hybrids as potential antimalarial agents. It also presents a brief and simplified story on the development of 4-aminoquinolines as a mainstay in malarial research programmes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/1568026614666140808125728 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Synthesis and Structure-Activity Relationship (SAR) Studies on New 4-Aminoquinoline-Hydrazones and Isatin Hybrids as Promising Antibacterial Agents.
Molecules
December 2024
Medicinal Chemistry Laboratory, Department of Biosciences, Jamia Millia Islamia, New Delhi 110025, India.
In response to the escalating crisis of antimicrobial resistance (AMR), there is an urgent need to research and develop novel antibiotics. This study presents the synthesis and assessment of innovative 4-aminoquinoline-benzohydrazide-based molecular hybrids bearing aryl aldehydes () and substituted isatin warheads (), characterized using multispectroscopic techniques with high purity confirmed by HRMS. The compounds were evaluated against a panel of clinically relevant antibacterial strains including the Gram-positive , , and and a Gram-negative bacterial strain.
View Article and Find Full Text PDFDesign, synthesis and mechanistic exploration of anti-plasmodial Indolo[2,3-]quinoxaline-7-chloroquinoline hybrids.
Future Med Chem
December 2024
Department of Chemistry, Guru Nanak Dev University, Amritsar, India.
The aim of this study is to synthesize indolo[2,3-]quinoxaline-4-aminoquinoline-based hybrids and evaluate their effectiveness against chloroquine-susceptible (3D7) and resistant (W2) strains, with expected inhibition of chloroquine resistance transporter (CRT) and heme. The hybrids were synthesized and evaluated against both susceptible and resistant strains. Molecular docking and studies were conducted to assess the binding affinities for the CRT protein.
View Article and Find Full Text PDFA novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistance with PfCRT and PfMDR1 mutants.
PLoS Pathog
October 2024
Laboratory of Tropical Diseases-Prof. Dr. Luiz Jacintho da Silva, Department of Genetics, Evolution, Microbiology and Immunology, University of Campinas-UNICAMP, Campinas, São Paulo, Brazil.
Artemisinin-based combination therapy (ACT) is the mainstay of effective treatment of Plasmodium falciparum malaria. However, the long-term utility of ACTs is imperiled by widespread partial artemisinin resistance in Southeast Asia and its recent emergence in parts of East Africa. This underscores the need to identify chemotypes with new modes of action (MoAs) to circumvent resistance to ACTs.
View Article and Find Full Text PDFIdentification of potent and orally efficacious phosphodiesterase inhibitors in Cryptosporidium parvum-infected immunocompromised male mice.
Nat Commun
September 2024
Department of Medicine, University of Vermont Larner College of Medicine, Room 202 Stafford Hall, 95 Carrigan Drive, Burlington, Vermont, USA.
Article Synopsis
- Cryptosporidium parvum and C. hominis are dangerous parasites causing severe diarrhea, particularly in children and people with weakened immune systems, with limited treatment options available.
- Researchers screened 278 compounds and discovered that certain pyrazolopyrimidine human phosphodiesterase (PDE)-V inhibitors showed strong effectiveness against these parasites in infected mice, targeting their ability to exit host cells and demonstrating minimal side effects.
- The study identified CpPDE1 as a crucial target for these inhibitors, as mutations in this enzyme affect the efficiency of treatment, opening new avenues for developing more effective therapies against Cryptosporidium infections.
Hybrids of 3-Hydroxypyridin-4(1)-ones and Long-Chain 4-Aminoquinolines as Potent Biofilm Inhibitors of Potentiate Tobramycin and Polymyxin B Activity.
J Med Chem
September 2024
International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, #855 Xingye Avenue, Guangzhou 511400, China.
The biofilm formation of involves multiple complex regulatory pathways; thus, blocking a single pathway is unlikely to achieve the desired antibiofilm efficacy. Herein, a series of hybrids of 3-hydroxypyridin-4(1)-ones and long-chain 4-aminoquinolines were synthesized as biofilm inhibitors against based on a multipathway antibiofilm strategy. Comprehensive structure-activity relationship studies identified compound as the most valuable antagonist, which significantly inhibited biofilm formation (IC = 5.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!